ACTRN12621000595819招募中2 期
ITHRIVE: Iron and erythropoietin use in anaemic patients in intensive care
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 550
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Adult patient who has required ICU-level care for more than 48 hours
- •2.The treating clinician has determined that ICU discharge is appropriate or is likely to be appropriate in the next 24 hours
- •3.Haemoglobin <100g/L on the most recent usual care measurement within the last 24 hours
排除标准
- •1. Received IV iron therapy or ESA therapy in the last three months
- •2. Active cancer+
- •3. The treating clinician believes that trial participation is not in the best interests of the patient
- •4. The treating clinician believes death during this hospital admission is inevitable
- •5. Any history of adverse reaction to IV iron or ESA therapy, or therapies derived from mammalian cells
- •6. Blood products are contraindicated
- •7. Receiving antibiotic therapy with a planned total therapy duration >10 days^
- •8. Thromboembolism chemoprophylaxis is contraindicated
- •9. Resident in a nursing home or high-level chronic care facility
- •10. Pregnancy or breast feeding
- •11. Weight less than 50 kg
- •12. Porphyria
- •13. Previously enrolled in ITHRIVE
研究者
相似试验
进行中（未招募）
1 期
INtravevous Iron to Treat Anaemia in CriTical Care Survivors (INTACT): a feasibility studyEUCTR2018-000767-91-GBniversity of Oxford / Clinical Trials and Research Governance130
已完成
3 期
Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve ReplacementAnemiaAortic StenosisNCT02390102Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec117
进行中（未招募）
1 期
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatioiron deficiency anemiaEUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
已完成
不适用
Dysregulation of Iron and Ranal Anemia Treatment in patients with chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000006833Hyogo College of Medicine250
进行中（未招募）
1 期
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT